Stay updated with breaking news from Antiverse Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antiverse Ltd (Antiverse) and GlobalBio, Inc. (GlobalBio) today announced they will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy.
$3 million USD (c. £2.5 million GBP) investment will enable further development of assets Successful identification of 8 antibodies with therapeutic potential for human GPCRs achieved
Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.